全文获取类型
收费全文 | 19831篇 |
免费 | 1825篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 163篇 |
儿科学 | 725篇 |
妇产科学 | 450篇 |
基础医学 | 2852篇 |
口腔科学 | 319篇 |
临床医学 | 2668篇 |
内科学 | 3748篇 |
皮肤病学 | 268篇 |
神经病学 | 2062篇 |
特种医学 | 524篇 |
外科学 | 2049篇 |
综合类 | 765篇 |
一般理论 | 21篇 |
预防医学 | 1960篇 |
眼科学 | 488篇 |
药学 | 1232篇 |
中国医学 | 12篇 |
肿瘤学 | 1398篇 |
出版年
2023年 | 134篇 |
2022年 | 183篇 |
2021年 | 412篇 |
2020年 | 282篇 |
2019年 | 399篇 |
2018年 | 547篇 |
2017年 | 349篇 |
2016年 | 404篇 |
2015年 | 391篇 |
2014年 | 568篇 |
2013年 | 912篇 |
2012年 | 1160篇 |
2011年 | 1151篇 |
2010年 | 678篇 |
2009年 | 583篇 |
2008年 | 1093篇 |
2007年 | 1123篇 |
2006年 | 1099篇 |
2005年 | 1109篇 |
2004年 | 980篇 |
2003年 | 891篇 |
2002年 | 870篇 |
2001年 | 488篇 |
2000年 | 445篇 |
1999年 | 434篇 |
1998年 | 234篇 |
1997年 | 193篇 |
1996年 | 208篇 |
1995年 | 196篇 |
1994年 | 140篇 |
1993年 | 166篇 |
1992年 | 300篇 |
1991年 | 300篇 |
1990年 | 306篇 |
1989年 | 257篇 |
1988年 | 227篇 |
1987年 | 245篇 |
1986年 | 211篇 |
1985年 | 176篇 |
1984年 | 179篇 |
1983年 | 155篇 |
1982年 | 117篇 |
1981年 | 98篇 |
1980年 | 90篇 |
1979年 | 123篇 |
1978年 | 116篇 |
1977年 | 91篇 |
1976年 | 82篇 |
1975年 | 76篇 |
1970年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Antiserum raised to a factor elaborated by a lymphoblastoid cell line derived from the peripheral blood cells of an HLA-B27 positive patient with ankylosing spondylitis specifically lyses the B27 positive, but not the B27 negative, cells of ankylosing spondylitis patients. The cells of B27 positive and B27 negative normal controls are not lysed. This serum has similar specificity to antisera against cross-reactive bacteria. 相似文献
33.
34.
Margaret Sullivan Pepe Ziding Feng Gary Longton Joseph Koopmeiners 《Statistics in medicine》2009,28(5):762-779
Development of a disease screening biomarker involves several phases. In phase 2 its sensitivity and specificity is compared with established thresholds for minimally acceptable performance. Since we anticipate that most candidate markers will not prove to be useful and availability of specimens and funding is limited, early termination of a study is appropriate, if accumulating data indicate that the marker is inadequate. Yet, for markers that complete phase 2, we seek estimates of sensitivity and specificity to proceed with the design of subsequent phase 3 studies. We suggest early stopping criteria and estimation procedures that adjust for bias caused by the early termination option. An important aspect of our approach is to focus on properties of estimates conditional on reaching full study enrollment. We propose the conditional‐UMVUE and contrast it with other estimates, including naïve estimators, the well‐studied unconditional‐UMVUE and the mean and median Whitehead‐adjusted estimators. The conditional‐UMVUE appears to be a very good choice. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
35.
Deborah Witt Sherman Marianne LaPorte Matzo Patrick Coyne Betty R Ferrell Barbara K Penn 《Journal for nurses in staff development》2004,20(3):103-15; quiz 116-7
Relief of symptoms for patients and families throughout the illness trajectory requires that palliative care practitioners have knowledge and skill, both in assessment and use of pharmacologic and complementary therapies. This article presents the didactic content of symptom assessment and management, and the experiential experiences used in a nondrug laboratory within the End-of-Life Nursing Education Consortium (ELNEC) curriculum. 相似文献
36.
Nathan J Koewler Katie T Freeman Ryan J Buus Monica B Herrera Juan M Jimenez-Andrade Joseph R Ghilardi Christopher M Peters Lucy J Sullivan Michael A Kuskowski Jack L Lewis Patrick W Mantyh 《Journal of bone and mineral research》2007,22(11):1732-1742
A closed femur fracture pain model was developed in the C57BL/6J mouse. One day after fracture, a monoclonal antibody raised against nerve growth factor (anti-NGF) was delivered intraperitoneally and resulted in a reduction in fracture pain-related behaviors of approximately 50%. Anti-NGF therapy did not interfere with bone healing as assessed by mechanical testing and histomorphometric analysis. INTRODUCTION: Current therapies to treat skeletal fracture pain are limited. This is because of the side effect profile of available analgesics and the scarcity of animal models that can be used to understand the mechanisms that drive this pain. Whereas previous studies have shown that mineralized bone, marrow, and periosteum are innervated by sensory and sympathetic fibers, it is not understood how skeletal pain is generated and maintained even in common conditions such as osteoarthritis, low back pain, or fracture. MATERIALS AND METHODS: In this study, we characterized the pain-related behaviors after a closed femur fracture in the C57BL/6J mouse. Additionally, we assessed the effect of a monoclonal antibody that binds to and sequesters nerve growth factor (anti-NGF) on pain-related behaviors and bone healing (mechanical properties and histomorphometric analysis) after fracture. RESULTS: Administration of anti-NGF therapy (10 mg/kg, days 1, 6, and 11 after fracture) resulted in a reduction of fracture pain-related behaviors of approximately 50%. Attenuation of fracture pain was evident as early as 24 h after the initial dosing and remained efficacious throughout the course of fracture pain. Anti-NGF therapy did not modify biomechanical properties of the femur or histomorphometric indices of bone healing. CONCLUSIONS: These findings suggest that therapies that target NGF or its cognate receptor(s) may be effective in attenuating nonmalignant fracture pain without interfering with bone healing. 相似文献
37.
38.
39.
Diagnosis of somatisation: effect of an educational intervention in a cluster randomised controlled trial. 下载免费PDF全文
Marianne Rosendal Flemming Bro Per Fink Kaj Sparle Christensen Frede Olesen 《The British journal of general practice》2003,53(497):917-922
BACKGROUND: Somatisation is highly prevalent in primary care (present in 25% of visiting patients) but often goes unrecognised. Non-recognition may lead to ineffective treatment, risk of iatrogenic harm, and excessive use of healthcare services. AIM: To examine the effect of training on diagnosis of somatisation in routine clinical practice by general practitioners (GPs). DESIGN OF STUDY: Cluster randomised controlled trial, with practices as the randomisation unit. SETTING: Twenty-seven general practices (with a total of 43 GPs) in Vejle County, Denmark. METHOD: Intervention consisted of a multifaceted training programme (the TERM [The Extended Reattribution and Management] model). Patients were enrolled consecutively over a period of 13 working days. Psychiatric morbidity was assessed by means of a screening questionnaire. GPs categorised their diagnoses in another questionnaire. The primary outcome was GP diagnosis of somatisation and agreement with the screening questionnaire. RESULTS: GPs diagnosed somatisation less frequently than had previously been observed, but there was substantial variation between GPs. The difference between groups in the number of diagnoses of somatisation failed to reach the 5% significance (P = 0.094). However, the rate of diagnoses of medically unexplained physical symptoms was twice as high in the intervention group as in the control group (7.7% and 3.9%, respectively, P = 0.007). Examination of the agreement between GPs' diagnoses and the screening questionnaire revealed no significant difference between groups. CONCLUSION: Brief training increased GPs' awareness of medically unexplained physical symptoms. Diagnostic accuracy according to a screening questionnaire remained unaffected but was difficult to evaluate, as there is no agreement on a gold standard for somatisation in general practice. 相似文献
40.
During the past 10 years, numerous phase I-II studies were conducted and provided clinical experience with combined radiation therapy and hyperthermia treatments. Among the rare complications reported in these combined radiation therapy-hyperthermia trials were myonecrosis and peripheral neuropathy which were felt, mainly on a clinical basis, to be caused by local heat damage. Recently, such complications were noted in two patients with recurrent prostatic cancer treated in our department with radiation therapy combined with deep regional hyperthermia delivered by the Sigma-60 applicator of the BSD 2000 hyperthermia system (Salt Lake City, UT, USA). Analysis of the results of three-dimensional modelling of the SAR (specific absorption rate, W/kg) pattern in these patients indicated high SAR at the sites of the complications. Pretreatment three-dimensional modelling or other methods of predicting potential areas of high power deposition may have a role for future hyperthermia treatment planning aiding in the prevention of possible local heat damage and providing improved delivery of heat to the target volume. 相似文献